Aspira Pathlab & Diagnostics Ltd Peer Comparison
ASPIRA · Healthcare Services · Current price ₹97
Peers tracked
11
Aspira Pathlab & Diagnostics Ltd P/E
48.3x
Sector
Healthcare Services
Aspira Pathlab & Diagnostics Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | ₹8,650 | 64.4x | 1,24,405 |
| MAX HEALTHCARE INS LTD | ₹984.8 | 76.1x | 95,938 |
| MANIPAL HEALTH ENTERPRI L | ₹725.2 | 115.8x | 93,379 |
| FORTIS HEALTHCARE LTD | ₹905 | 70.6x | 68,952 |
| ASTER DM QUALITY CARE LTD | ₹785.75 | 105.6x | 40,731 |
| GLOBAL HEALTH LIMITED | ₹1,469.8 | 65.0x | 39,525 |
| NARAYANA HRUDAYALAYA LTD. | ₹1,858.5 | 50.4x | 37,970 |
| DR. LAL PATH LABS LTD. | ₹1,877.5 | 54.8x | 31,446 |
| KRISHNA INST OF MED SCI L | ₹764.1 | 139.0x | 30,587 |
| POLY MEDICURE LIMITED | ₹1,702.5 | 54.5x | 17,256 |
| Aspira Pathlab & Diagnostics Ltd | — | -204.0x | 94 |
Aspira Pathlab & Diagnostics Ltd versus its peers
Aspira Pathlab & Diagnostics Ltd operates in the Healthcare Services space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 48.3x may be cheap in one industry and expensive in another.
More on Aspira Pathlab & Diagnostics Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.